SeanSwinford

Associate

Washington + 1.202.879.3649

Connect:

Share

Sean Swinford joined our New Lawyers Group (NLG) in 2023. The NLG provides our newest lawyers with the opportunity to gain exposure to different practice areas and lawyering styles before making a commitment to a specific practice. Individuals in the NLG may focus on a particular area of practice, or compare practices, during their first year with Jones Day.

Experience

  • Reneo Pharmaceuticals announces reverse merger with OnKureJones Day is representing Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) in an all-stock reverse merger between Reneo and OnKure, Inc., a privately-held, clinical-stage biopharmaceutical company valued at $170 million that is focused on the development of novel precision medicines in oncology.
    • View All

    APRIL 2024 Alert

    New State Health Privacy Laws—Moving Beyond HIPAA and Recasting Consumer Health Data Rights?

    February 2024 Alert

    HHS Releases Cybersecurity Performance Goals to Enhance Cybersecurity for Health Care and Public Health Sectors

    January 2024 Alert

    HHS Announces Upcoming Federal Strategies to Enhance Cybersecurity for Health Care and Public Health Sectors

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.